Safety of cardiovascular magnetic resonance gadolinium chelates contrast agents in patients with hemoglobinopathies

Haematologica

Volumn 94, Issue 11, 2009, Pages 1625-1627

  Meloni, Antonella ^a   Favilli, Brunella ^a   Positano, Vincenzo ^a   Cianciulli, Paolo ^b   Filosa, Aldo ^c   Quarta, Antonella ^d   D'Ascola, Domenico ^e   Restaino, Gennaro ^f   Lombardi, Massimo ^a   Pepe, Alessia ^a  

^a FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

^b S EUGENIO HOSPITAL   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

^d A Perrino Hospital   (Italy)

^e BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBUTROL; GADOLINIUM CHELATE; GADOLINIUM PENTETATE;

ADULT; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HEMOGLOBINOPATHY; HUMAN; KIDNEY DYSFUNCTION; LETTER; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK ASSESSMENT; URTICARIA; VOMITING;

ADOLESCENT; ADULT; CHILD; CONTRAST MEDIA; DRUG TOXICITY; FEMALE; GADOLINIUM; HEMOGLOBINOPATHIES; HUMANS; KIDNEY DISEASES; MALE; YOUNG ADULT;

EID: 70449380245     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.010181     Document Type: Letter

References (9)

1. Meloni A, Pepe A, Positano V, Favilli B, Maggio A, Capra M, et al. Influence of myocardial fibrosis and blood oxygenation on heart T2* values in thalassemia patients. J Magn Reson Imaging 2009;29:832-837
2. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001;357:21-28 (Pubitemid 32056497)
3. Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2007;2:264-267
4. DeHoratius DM, Cowper SE. Nephrogenic systemic fibrosis: an emerging threat among renal patients. Semin Dial 2006;19:191-194
5. Perazella MA, Rodby RA. Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 2007;20:179-185
6. Perazella MA. Gadolinium-contrast toxicity in patients with kidney disease: nephrotoxicity and nephrogenic systemic fibrosis. Curr Drug Saf 2008;3:67-75.
7. Meloni A, Ramazzotti A, Positano V, Salvatori C, Mangione M, Marcheschi P, et al. Evaluation of a web-based network for reproducible T2* MRI assessment of iron overload in thalassemia. Int J Med Inform 2009;78:503-512
8. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470 (Pubitemid 29135798)
9. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-263